Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Spray-Dried Biologics Market Growth Potential: How Will Market Size Shift Through 2030?
The spray-dried biologics market has expanded considerably in recent times. It is anticipated to increase in value from $1.86 billion in 2025 to $2.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical development of this market is due to several factors, including developments in biologics formulation science, a rise in biologic drug approvals, the requirement for improved drug stability, growth in vaccine manufacturing capacity, and the implementation of advanced pharmaceutical processing technologies.
The spray-dried biologics market is projected to experience substantial expansion over the coming years, with its size forecasted to reach $3.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.4%. This growth during the prediction period is largely driven by a rising demand for non-injectable biologics, increased capital allocation in dry powder delivery technologies, the growth of global vaccine manufacturing, an increased emphasis on minimizing cold-chain requirements, and improvements in spray-drying equipment technology. Key trends anticipated during the forecast period involve the wider acceptance of spray-drying for improving biologic stability, an escalating need for inhalable and orally administered biologic formulations, the expansion of continuous spray-drying methods, the growing application of dry powder biologics in vaccines, and a heightened emphasis on extending product shelf-life.
Get A Free Sample Report With In-Depth Market Insights:
Spray-Dried Biologics Market Growth Factors Behind Sustained Expansion
The escalating demand for biopharmaceuticals is anticipated to fuel the expansion of the spray-dried biologics market moving forward. Biopharmaceuticals are therapeutic products sourced from biological origins, including living cells, proteins, and other biomolecules. The need for biopharmaceuticals is increasing globally due to a rise in chronic and complex health conditions, which creates a critical requirement for treatments offering enhanced specificity, improved efficacy, and reduced systemic side effects. The spray-dried biologics industry is observing growing demand as the swift growth of biopharmaceuticals prompts companies to implement scalable formulation technologies that enhance stability, extend shelf life, and optimize delivery efficiency. For instance, in February 2025, the World Health Organization (WHO), a Switzerland-based international public health agency, noted that its 2023 essential medicines list (EML) included 81 biologic therapies, accounting for more than 15% of all essential medicines. Thus, the increasing demand for biopharmaceuticals is propelling the growth of the spray-dried biologics market.
Spray-Dried Biologics Market Segmentation: How Does The Market Break Down By Category?
The spray-dried biologics market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types
2) By Route Of Administration: Oral, Inhalation Or Pulmonary, Injectable, Topical
3) By End-User: Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Monoclonal Antibodies: Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments
2) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines
3) By Enzymes: Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes
4) By Hormones: Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones
5) By Other Product Types: Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins
Spray-Dried Biologics Market Industry Trends Fueling Future Revenue Growth
Major companies operating in the spray-dried biologics market are focusing on incorporating technological advancements, such as drum dosing technology, to enhance dose accuracy, powder handling efficiency, and reliable large-scale capsule filling. Drum dosing technology is an advanced powder-filling method that uses a rotating drum with precision-engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules, enabling capabilities such as consistent low-dose filling, improved flow management of spray-dried powders, and high-throughput scalability. For instance, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), upgraded its inhalation manufacturing facility in the US by adding potent capsule-filling capabilities powered by drum-based dosing systems and in-line advanced mass verification. The upgraded platform supports accurate filling of engineered and spray-dried powders, featuring real-time dose validation and controlled low-humidity processing. This enhancement improves manufacturing efficiency, product consistency, and readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.
Spray-Dried Biologics Market Competitive Overview And Top Companies
Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BÜCHI Labortechnik AG.
View The Full Spray-Dried Biologics Market Report:
Spray-Dried Biologics Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model